© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Top Medical News
Switch to Siponimod Safe, Tolerable With No Washout, Study Finds
April 18, 2021
By Alicia Bigica
Results from the ongoing clinical trial will help define clinical management guidelines for switching patients with relapsing MS on other disease-modifying therapies to siponimod.
Multiple Independent Current Control DBS Associated With Improved Outcomes in Parkinson Disease
April 18, 2021
By Marco Meglio
No stimulation adverse effects were reported, and patients on the MICC stimulation alone resulted in greater than 50% improvement in UPDRS motor scores.
Simple Interventions Improve Compliance With Patient-Specific Stroke Discharge Instructions
April 17, 2021
By Victoria Johnson
Researchers from Ascension Saint Agnes improved compliance in their hospital in providing patient-specific, stroke-dedicated discharge instructions.
Rimegepant Safe in Patients With Prior Triptan Failure
April 17, 2021
By Marco Meglio
Serious adverse events occurred in 3.7% and 2.4% of subjects in the subgroups of patients with 1 and 2 or more triptan failures, respectively.
Negative Impacts on Cognition Not Observed With Pimavanserin for Dementia-Related Psychosis
April 16, 2021
By Victoria Johnson
The study presented at the 2021 AAN Meeting follows the complete response letter issued by the FDA to Acadia Pharmaceuticals due to deficiencies in their sNDA.
